FDA Inspection 1038581 — Garaventa (Canada), Ltd.

Garaventa (Canada), Ltd. — FEI 3002807131

The FDA completed an inspection of Garaventa (Canada), Ltd. on Jan 18, 2018 in Surrey. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 9 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 18, 2018
Fiscal Year
2018
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Surrey (Canada)

Citations

IDCFRDescription
1471421 CFR 820.30(c)Design input - Lack of or inadequate procedures
1471821 CFR 820.30(g)Design validation - Risk analysis
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
260421 CFR 820.30(e)Design review - Lack of or inadequate procedures
311721 CFR 820.70(i)Software validation for automated processes
312121 CFR 820.80(b)Lack of or inadequate receiving acceptance procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
48621 CFR 820.50(a)Evaluation of suppliers, contractors, etc., requirements

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.